Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183430 · ClinicalTrials.gov registry record · NA
Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder
A NA study, sponsored by Seattle Institute for Biomedical and Clinical Research.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00183430 is a NA study that was terminated before completion, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 20 participants.
The verdict
NCT00183430, a NA study, was terminated before completion, sponsored by Seattle Institute for Biomedical and Clinical Research.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of prazosin in treating post-traumatic stress disorder caused by noncombat trauma in individuals taking selective serotonin reuptake inhibitors.
Interventions
- DRUG Placebo
- BEHAVIORAL Psychotherapy
- DRUG Prazosin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2003-10 |
| Est. Completion | 2010-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00183430
The ClinicalTrials.gov registry entry for NCT00183430 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Institute for Biomedical and Clinical Research, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00183430 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00183430 about?
NCT00183430 is a clinical study titled "Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder". This study will evaluate the effectiveness of prazosin in treating post-traumatic stress disorder caused by noncombat trauma in individuals taking selective serotonin reuptake inhibitors.
What is the current status of trial NCT00183430?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2003-10. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00183430?
The interventions under investigation include: Placebo (DRUG), Psychotherapy (BEHAVIORAL), Prazosin (DRUG).
Who is sponsoring clinical trial NCT00183430?
This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.